GB0710844D0 - Potassium ion channel modulators & uses thereof - Google Patents

Potassium ion channel modulators & uses thereof

Info

Publication number
GB0710844D0
GB0710844D0 GBGB0710844.2A GB0710844A GB0710844D0 GB 0710844 D0 GB0710844 D0 GB 0710844D0 GB 0710844 A GB0710844 A GB 0710844A GB 0710844 D0 GB0710844 D0 GB 0710844D0
Authority
GB
United Kingdom
Prior art keywords
ion channel
potassium ion
channel modulators
modulators
potassium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0710844.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lectus Therapeutics Ltd
Original Assignee
Lectus Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lectus Therapeutics Ltd filed Critical Lectus Therapeutics Ltd
Priority to GBGB0710844.2A priority Critical patent/GB0710844D0/en
Publication of GB0710844D0 publication Critical patent/GB0710844D0/en
Priority to PCT/GB2008/050423 priority patent/WO2008149163A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
GBGB0710844.2A 2007-06-06 2007-06-06 Potassium ion channel modulators & uses thereof Ceased GB0710844D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0710844.2A GB0710844D0 (en) 2007-06-06 2007-06-06 Potassium ion channel modulators & uses thereof
PCT/GB2008/050423 WO2008149163A2 (en) 2007-06-06 2008-06-06 Potassium ion channel modulators and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0710844.2A GB0710844D0 (en) 2007-06-06 2007-06-06 Potassium ion channel modulators & uses thereof

Publications (1)

Publication Number Publication Date
GB0710844D0 true GB0710844D0 (en) 2007-07-18

Family

ID=38318820

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0710844.2A Ceased GB0710844D0 (en) 2007-06-06 2007-06-06 Potassium ion channel modulators & uses thereof

Country Status (2)

Country Link
GB (1) GB0710844D0 (en)
WO (1) WO2008149163A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0723794D0 (en) 2007-12-05 2008-01-16 Lectus Therapeutics Ltd Potassium ion channel modulators and uses thereof
GB0909672D0 (en) 2009-06-04 2009-07-22 Xention Discovery Ltd Compounds
GB0909671D0 (en) 2009-06-04 2009-07-22 Xention Discovery Ltd Compounds
US9487526B2 (en) 2012-08-13 2016-11-08 Takeda Pharmaceutical Company Limited Quinoxaline derivatives as GPR6 modulators
JO3466B1 (en) 2013-12-20 2020-07-05 Takeda Pharmaceuticals Co Tetrahydropyridopyrazines modulators of gpr6
RS59007B1 (en) 2014-02-03 2019-08-30 Vitae Pharmaceuticals Llc Dihydropyrrolopyridine inhibitors of ror-gamma
EP3105230B1 (en) 2014-02-14 2021-04-07 Takeda Pharmaceutical Company Limited Pyridopyrazines modulators of gpr6
SI3207043T1 (en) 2014-10-14 2019-04-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ror-gamma
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
US9845308B2 (en) 2014-11-05 2017-12-19 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ROR-gamma
US10301261B2 (en) 2015-08-05 2019-05-28 Vitae Pharmaceuticals, Llc Substituted indoles as modulators of ROR-gamma
EP3868750A1 (en) 2015-11-20 2021-08-25 Vitae Pharmaceuticals, LLC Modulators of ror-gamma
CN108884093B (en) 2016-01-15 2021-07-09 辉瑞公司 Dopamine D3 ligand compound
TWI757266B (en) 2016-01-29 2022-03-11 美商維它藥物有限責任公司 Modulators of ror-gamma
US9481674B1 (en) 2016-06-10 2016-11-01 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
CN107021965B (en) * 2017-05-16 2019-08-13 无锡捷化医药科技有限公司 A method of synthesis -2 amine of 5,6,7,8- tetrahydro -1,6- naphthyridines
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. Inhibitors of ror gamma
EP3658555A1 (en) 2017-07-24 2020-06-03 Vitae Pharmaceuticals, LLC Inhibitors of ror
TWI803177B (en) * 2021-02-05 2023-05-21 大陸商賽諾哈勃藥業（成都）有限公司 Plasmin inhibitor, preparation method and application thereof
WO2023231966A1 (en) * 2022-05-30 2023-12-07 赛诺哈勃药业（成都）有限公司 Use of tetrahydronaphthyridine derivative for preparing product for improving hyperpigmentation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374643A (en) * 1992-09-11 1994-12-20 E. R. Squibb & Sons, Inc. Aryl urea (thiourea) and cyanoguanidine derivatives
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds

Also Published As

Publication number Publication date
WO2008149163A2 (en) 2008-12-11
WO2008149163A3 (en) 2009-04-09

Similar Documents

Publication Publication Date Title
GB0710844D0 (en) Potassium ion channel modulators & uses thereof
GB0619176D0 (en) Ion channel modulators & uses thereof
GB0813403D0 (en) Potassium ion channel modulators & uses thereof
GB0723794D0 (en) Potassium ion channel modulators and uses thereof
EP2178373A4 (en) Heterocycles as potassium channel modulators
EP2257678A4 (en) Channel
EP2073799A4 (en) Novel agents of calcium ion channel modulators
EP1723123A4 (en) Ion channel modulators
EP1723117A4 (en) Ion channel modulators
EP2194108A4 (en) Sealing member
EP2201078A4 (en) Improved sealing composition
EP1722783A4 (en) Ion channel modulators
EP1722788A4 (en) Ion channel modulators
GB0717073D0 (en) Ion channel modulator combinations and uses thereof
EP2114870A4 (en) Synthetic ion channels
EP1723120A4 (en) Ion channel modulators
GB2449822B (en) Functional metallicity ion band
GB0817576D0 (en) Calcium ion channel modulators & uses thereof
ZA201100068B (en) Calcium ion channel modulators & uses thereof
EP1723119A4 (en) Ion channel modulators
EP1722787A4 (en) Ion channel modulators
EP1722784A4 (en) Ion channel modulators
GB0822725D0 (en) Channel
EP1725523A4 (en) Ion channel modulators
EP1722785A4 (en) Ion channel modulators

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)